Sciecure UK was set up in 2013 and its office serves as the European Headquarters.  The service of pharmacovigilance, regulatory, quality and customer service is located there. Sciecure UK provides safe, cost effective healthcare to improve the standard of living in the UK and the service standard of international market.

Sciecure Pharma commercialize and supply finished product under supply contract, if you are interested in distribute any of our products in your territories, please contact us.

1. Marketing Authorization（MA）of  Zoledronic acid injection 4mg/5ml is granted by Germany Federal Institute for Drugs and Medical Devices on 02 August 2016.
2. Marketing Authorization (MA) of  Aripiprazole 5mg, 10mg, 15mg, and 30mg tablets are granted by UK MHRA on 30 September, 2016.
3. Marketing Authorization (MA) of  Voriconazole 50mg and 200mg tablets are granted by UK MHRA on 07 October, 2016.
4. Marketing Authorization（MA）of Levetiracetam 100mg/ml concentrate for solution for infusion is granted by Germany Federal Institute for Drugs and Medical Devices on 19 January 2017.
5. Marketing Authorization (MA) of  Pregabalin 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg and 300mg hard capsules are granted by UK MHRA on 20 January, 2017.
6. Marketing Authorization (MA) of  Levetiracetam 100mg/ml concentrate for solution for infusion is granted by UK MHRA on 15 February, 2017.
7. Marketing Authorization (MA) of  Candesartan Cilexetil 2mg, 4mg, 8mg, 16mg, 32mg Tablets are granted by UK MHRA on 03 May, 2017.

8. Marketing Authorization (MA) of  Valsartan 40mg, 80mg, 160mg and 320mg film-coated Tablets are granted by UK MHRA on 05 June, 2017.

9. Marketing Authorization (MA) of  Levetiracetam Sciecure 250mg, 500mg, 750mg and 1000mg film-coated Tablets are granted by UK MHRA on 12 July, 2017.

10. Marketing Authorization (MA) of  Valsartan Hydrochlorothiazide 80/12.5mg, 160/12.5mg, 160/25mg film-coated Tablets are granted by UK MHRA on 26 July, 2017.

11. Marketing Authorization (MA) of  Clopidogrel Sciecure 75mg film-coated tablets are granted by UK MHRA on 18 August, 2017.

12. Marketing Authorization (MA) of  Aripiprazole Sciecure 10mg and 15mg orodispersible tablets are granted by UK MHRA on 05 September, 2017.

These are the great achievements for our company, and we will continue to develop more high quality drugs to benefit the societies.

13. Marketing Authorization (MA) of  Celecoxib capsules 100mg & 200mg are granted by Portugal National Authority of  Medicines and Health Products on 09 November, 2017.

14. Marketing Authorization (MA) of Telmisartan 20mg, 40mg, 80mg tablets are granted by UK MHRA on 31 January, 2018.

15. Marketing Authorization (MA) of Telmisartan Hydrochlorothiazide 80/12.5MG, 80/25MG tablets are granted by UK MHRA on 02 March, 2018.
16. Marketing Authorization (MA) of Irbesartan Hydrochlorothiazide 150/12.5mg, 300/12.5mg, 300/25mg film-coated tablets are granted by UK MHRA on 25 August, 2017.

17. Marketing Authorization (MA) of Irbesartan 75mg, 150mg, 300mg film-coated tablets are granted by UK MHRA on 29 March, 2018.
18. Marketing Authorization (MA) of Ondansetron 2 mg/ml Solution for Injection are granted by UK MHRA on 21 August, 2018.

19.Marketing Authorization (MA) of Cisatracurium besilate Sciecure 2 mg/ml and 5 mg/ml Solution for Injection/Infusion are granted by UK MHRA on 28 September, 2018.

20. Marketing Authorization (MA) of Voriconazole Sciecure 200 mg powder for solution for Infusion is granted by UK MHRA on 29 October, 2018.

These are the great achievements for our company, and we will continue to develop more high quality drugs to benefit the societies.